Clinical Trial Update: Study of Latiglutenase in T1D/CD Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating latiglutenase in patients with celiac disease (including those with type 1 diabetes) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• Latiglutenase (latiglutenase)

Snippet

Sponsor: Entero Therapeutics | Conditions: Celiac Disease | Phase 2 | Status: TERMINATED